Accessibility links
Health Inc. : Shots - Health News As spending on care rises, the business of health keeps getting more important. We feature news on and analysis of drugmakers, health insurers, hospitals, doctors and others in the business of providing health care.
Shots - Health News

Shots

Health News From NPR

Health Inc.

Wednesday

Tuesday

States Fear Price Of New Zika Vaccine Will Be More Than They Can Pay

French pharmaceutical group Sanofi is expected to receive an exclusive license to market a new Zika vaccine. AFP/AFP/Getty Images hide caption

toggle caption
AFP/AFP/Getty Images

Health Inc.

States Fear Price Of New Zika Vaccine Will Be More Than They Can Pay

The vaccine against Zika vaccine was developed by the Army, with the government paying for clinical trials, too. Health officials want to be sure drugmaker Sanofi Pasteur doesn't make it unaffordable.

States Fear Price Of New Zika Vaccine Will Be More Than They Can Pay

Listen · 3:55
  • Download
  • <iframe src="https://www.npr.org/player/embed/529887446/530697999" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

GOP Health Bill Penalizes Patients Who Let Insurance Lapse

There are many reasons someone could end up having a lapse in health insurance. They might need to move closer to a caregiver or treatment center, for example, and consequently have to quit their job — and lose their insurance. Portra Images/Getty Images hide caption

toggle caption
Portra Images/Getty Images

Health Inc.

GOP Health Bill Penalizes Patients Who Let Insurance Lapse

KFF Health News

In some states, a break in health coverage of more than 63 days would let insurers charge premiums of any price for a year — putting health insurance out of reach for many sick people, analysts say.

Tuesday

Tuesday

Tuesday

Saturday

U.S. Health Care Wrestles With The 'Pre-Existing Condition'

Carl Goulden, of Littlestown Pa., developed hepatitis B 10 years ago. Soon his health insurance premiums soared beyond a price he and his wife could afford. Elana Gordon/WHYY hide caption

toggle caption
Elana Gordon/WHYY

Health Inc.

U.S. Health Care Wrestles With The 'Pre-Existing Condition'

WHYY

Insurers and politicians struggle constantly to thread the needle between making sure people have good health insurance and figuring out who should pay, especially for those who need a lot of care.

U.S. Health Care Wrestles With The 'Pre-Existing Condition'

Listen · 3:56
  • Download
  • <iframe src="https://www.npr.org/player/embed/523577871/524076592" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Monday

How U.S. Health Care Became Big Business
Bill Diodato/Getty Images

Health Inc.

How U.S. Health Care Became Big Business

Fresh Air

Writer Elisabeth Rosenthal has worked as a physician and says it's far more lucrative in the U.S. health system to provide a lifetime of treatments than a cure. Her new book is An American Sickness.

How U.S. Health Care Became Big Business

Listen · 36:03
  • Download
  • <iframe src="https://www.npr.org/player/embed/523005353/523293393" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Monday

Recall Of Some EpiPens Extends To U.S.

An EpiPen Jr. epinephrine auto-injector. Some EpiPens have been recalled from the U.S. market over concerns that they could fail to activate when people try to use them. Chris Ratcliffe/Bloomberg via Getty Images hide caption

toggle caption
Chris Ratcliffe/Bloomberg via Getty Images

Your Health

Recall Of Some EpiPens Extends To U.S.

Mylan is recalling some EpiPens distributed between December 2015 and July 2016, saying a potentially defective part could make them fail to activate during a life-threatening allergic reaction.

Tuesday

Sunday

Friday

Friday

Should The U.S. Government Buy A Drug Company To Save Money?

Gilead Sciences Inc. makes the two leading drugs that can quickly cure hepatitis C infections. But most patients can't afford the expensive drugs, and states restrict their use among Medicaid patients. David Paul Morris/Bloomberg via Getty Images hide caption

toggle caption
David Paul Morris/Bloomberg via Getty Images

Health Inc.

Should The U.S. Government Buy A Drug Company To Save Money?

Most of the millions in the U.S. who are infected with hepatitis C can't afford the cure. Some say the U.S. could save money and cure more people if it bought the drugmaker Gilead Sciences Inc.

Should The U.S. Government Buy A Drug Company To Save Money?

Listen · 3:55
  • Download
  • <iframe src="https://www.npr.org/player/embed/520430944/520576934" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights

Rep. Lloyd Doggett, D-Texas, is promoting a campaign to get the National Institutes of Health to exercise the patent rights it already owns in regards to certain drugs to bring down their price. Bill Clark/CQ-Roll Call, Inc. hide caption

toggle caption
Bill Clark/CQ-Roll Call, Inc.

Health Inc.

One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights

Some members of Congress say the U.S. government should use the patent rights it owns for any drugs that were developed with federal grants to drive down the prices of those drugs.

One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights

Listen · 4:00
  • Download
  • <iframe src="https://www.npr.org/player/embed/520390026/520440825" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Some See 'Flat-Fee Primary Care' As A GOP-Friendly Way To Provide Routine Care

Advocates of paying a family doctor a flat monthly fee for office visits and some lab work say it saves patients money when coupled with a high-deductible insurance plan. Ridofranz/Getty Images/iStockphoto hide caption

toggle caption
Ridofranz/Getty Images/iStockphoto

Health Inc.

Some See 'Flat-Fee Primary Care' As A GOP-Friendly Way To Provide Routine Care

KFF Health News

In "direct primary care," a model favored by HHS Secretary Tom Price, patients pay a monthly fee to doctors for basic health care. But does that really provide better value?